CERo Therapeutics Holdings, Inc.

The momentum for this stock is not very good. CERo Therapeutics Holdings, Inc. is not very popular among insiders. Tradey thinks it is not wise to invest in CERo Therapeutics Holdings, Inc..
Log in to see more information.
CERO Fundamental Data by TradingView

News

CERO Stock Earnings: CERo Therapeutics Hldgs Reported Results for Q2 2024
CERO Stock Earnings: CERo Therapeutics Hldgs Reported Results for Q2 2024

InvestorPlace InvestorPlace - Stock Market News, Stock Advice & Trading Tips\nCERo Therapeutics Hldgs just reported results for the second quarter of 2024.\nThe post CERO Stock Earnings: CERo Therapeutics Hldgs...\n more…

Cero Therapeutics presents CER-1236 data supporting use in AML
Cero Therapeutics presents CER-1236 data supporting use in AML

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…

CERo Therapeutics, Inc. Presents CER-1236 Data Supporting Use in AML at Global Cell & Gene Therapy Summit 2024
CERo Therapeutics, Inc. Presents CER-1236 Data Supporting Use in AML at Global Cell & Gene Therapy Summit 2024

Globe Newswire Company anticipates initial human trials to focus on AML upon IND clearance SOUTH SAN FRANCISCO, Calif., July 08, 2024 (GLOBE NEWSWIRE) -- CERo Therapeutics Holdings, Inc. (Nasdaq: CERO...\n more…

Cero Therapeutics completes IND-enabling manufacturing activities for CER-1236
Cero Therapeutics completes IND-enabling manufacturing activities for CER-1236

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…

CERo Therapeutics, Inc. Completes IND-Enabling Activities Following Successful Manufacturing Runs for Lead Compound CER-1236
CERo Therapeutics, Inc. Completes IND-Enabling Activities Following Successful Manufacturing Runs for Lead Compound CER-1236

Globe Newswire Company anticipates near term filing of Investigational New Drug Application to FDA SOUTH SAN FRANCISCO, Calif., June 13, 2024 (GLOBE NEWSWIRE) -- CERo Therapeutics Holdings, Inc. (Nasdaq: CERO...\n more…

CERo Therapeutics, Inc. Successfully Completes IND-Enabling Toxicology Studies for Lead Compound CER-1236
CERo Therapeutics, Inc. Successfully Completes IND-Enabling Toxicology Studies for Lead Compound CER-1236

Globe Newswire Company continuing IND-enabling activities in preparation for submission of Investigational New Drug Application to FDA SOUTH SAN FRANCISCO, Calif., June 06, 2024 (GLOBE NEWSWIRE) -- CERo...\n more…